Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
58
LFST Quote, Financials, Valuation and Earnings
Last price:
$7.30
Seasonality move
:
2.38%
Day range:
$6.92 - $7.34
52-week range:
$4.64 - $9.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.28x
P/B ratio:
1.94x
Volume:
2.3M
Avg. volume:
1.8M
1-year change:
-0.14%
Market cap:
$2.8B
Revenue:
$1.1B
EPS (TTM):
-$0.26
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LFST
LifeStance Health Group
|
$302.3M | -$0.01 | 11.29% | -95.93% | -- |
|
BKD
Brookdale Senior Living
|
$784.2M | -$0.21 | 3.6% | -40.6% | $7.38 |
|
ENSG
Ensign Group
|
$1.1B | $1.38 | 15.2% | 299.72% | $169.50 |
|
GRDN
Guardian Pharmacy Services
|
$303.2M | $0.19 | 14.04% | -49.94% | -- |
|
PACS
PACS Group
|
$981.5M | $0.34 | 12.05% | 19.71% | $34.83 |
|
PNTG
Pennant Group
|
$174.4M | $0.23 | 26.63% | 76.79% | $37.20 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LFST
LifeStance Health Group
|
$7.30 | -- | $2.8B | -- | $0.00 | 0% | 2.28x |
|
BKD
Brookdale Senior Living
|
$5.13 | $7.38 | $1B | -- | $0.00 | 0% | 0.38x |
|
ENSG
Ensign Group
|
$134.47 | $169.50 | $7.7B | 32.64x | $0.06 | 0.18% | 1.90x |
|
GRDN
Guardian Pharmacy Services
|
$21.41 | -- | $1.4B | -- | $0.00 | 0% | 1.13x |
|
PACS
PACS Group
|
$13.01 | $34.83 | $2B | 19.89x | $0.00 | 0% | 0.57x |
|
PNTG
Pennant Group
|
$27.38 | $37.20 | $940.5M | 40.26x | $0.00 | 0% | 1.29x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LFST
LifeStance Health Group
|
16.26% | 1.550 | 10.42% | 1.20x |
|
BKD
Brookdale Senior Living
|
92.68% | 0.112 | 273.65% | 0.58x |
|
ENSG
Ensign Group
|
7.74% | 0.187 | 1.82% | 1.46x |
|
GRDN
Guardian Pharmacy Services
|
25.69% | 0.000 | 4.12% | 0.81x |
|
PACS
PACS Group
|
46.18% | 0.000 | 10.9% | 1.57x |
|
PNTG
Pennant Group
|
39.13% | 0.492 | 9.9% | 0.98x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LFST
LifeStance Health Group
|
$100.4M | $47K | -5.57% | -6.64% | 0.01% | $17.7M |
|
BKD
Brookdale Senior Living
|
$198.1M | $11.2M | -5.08% | -54.76% | 1.17% | $11.5M |
|
ENSG
Ensign Group
|
$167M | $89.3M | 13.79% | 15.07% | 9.31% | $89M |
|
GRDN
Guardian Pharmacy Services
|
$60.9M | -$104.6M | -90.49% | -109.2% | -33.28% | -- |
|
PACS
PACS Group
|
$153.9M | $710K | -- | -- | -0.33% | -$76.7M |
|
PNTG
Pennant Group
|
$25.3M | $10.8M | 8.8% | 13.06% | 6.03% | $6.8M |
LifeStance Health Group vs. Competitors
-
Which has Higher Returns LFST or BKD?
Brookdale Senior Living has a net margin of -1.91% compared to LifeStance Health Group's net margin of -6.47%. LifeStance Health Group's return on equity of -6.64% beat Brookdale Senior Living's return on equity of -54.76%.
Company Gross Margin Earnings Per Share Invested Capital LFSTLifeStance Health Group32.12% -$0.02 $1.7B BKDBrookdale Senior Living25.27% -$0.22 $4B -
What do Analysts Say About LFST or BKD?
LifeStance Health Group has a consensus price target of --, signalling upside risk potential of 19.18%. On the other hand Brookdale Senior Living has an analysts' consensus of $7.38 which suggests that it could grow by 43.76%. Given that Brookdale Senior Living has higher upside potential than LifeStance Health Group, analysts believe Brookdale Senior Living is more attractive than LifeStance Health Group.
Company Buy Ratings Hold Ratings Sell Ratings LFSTLifeStance Health Group0 0 0 BKDBrookdale Senior Living2 0 0 -
Is LFST or BKD More Risky?
LifeStance Health Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Brookdale Senior Living has a beta of 1.288, suggesting its more volatile than the S&P 500 by 28.777%.
-
Which is a Better Dividend Stock LFST or BKD?
LifeStance Health Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Brookdale Senior Living offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeStance Health Group pays -- of its earnings as a dividend. Brookdale Senior Living pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LFST or BKD?
LifeStance Health Group quarterly revenues are $312.7M, which are smaller than Brookdale Senior Living quarterly revenues of $784.2M. LifeStance Health Group's net income of -$6M is higher than Brookdale Senior Living's net income of -$50.7M. Notably, LifeStance Health Group's price-to-earnings ratio is -- while Brookdale Senior Living's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeStance Health Group is 2.28x versus 0.38x for Brookdale Senior Living. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSTLifeStance Health Group2.28x -- $312.7M -$6M BKDBrookdale Senior Living0.38x -- $784.2M -$50.7M
-
Which has Higher Returns LFST or ENSG?
Ensign Group has a net margin of -1.91% compared to LifeStance Health Group's net margin of 7.25%. LifeStance Health Group's return on equity of -6.64% beat Ensign Group's return on equity of 15.07%.
Company Gross Margin Earnings Per Share Invested Capital LFSTLifeStance Health Group32.12% -$0.02 $1.7B ENSGEnsign Group15.44% $1.34 $1.9B -
What do Analysts Say About LFST or ENSG?
LifeStance Health Group has a consensus price target of --, signalling upside risk potential of 19.18%. On the other hand Ensign Group has an analysts' consensus of $169.50 which suggests that it could grow by 26.05%. Given that Ensign Group has higher upside potential than LifeStance Health Group, analysts believe Ensign Group is more attractive than LifeStance Health Group.
Company Buy Ratings Hold Ratings Sell Ratings LFSTLifeStance Health Group0 0 0 ENSGEnsign Group4 1 0 -
Is LFST or ENSG More Risky?
LifeStance Health Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ensign Group has a beta of 0.918, suggesting its less volatile than the S&P 500 by 8.238%.
-
Which is a Better Dividend Stock LFST or ENSG?
LifeStance Health Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ensign Group offers a yield of 0.18% to investors and pays a quarterly dividend of $0.06 per share. LifeStance Health Group pays -- of its earnings as a dividend. Ensign Group pays out 6.16% of its earnings as a dividend. Ensign Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios LFST or ENSG?
LifeStance Health Group quarterly revenues are $312.7M, which are smaller than Ensign Group quarterly revenues of $1.1B. LifeStance Health Group's net income of -$6M is lower than Ensign Group's net income of $78.4M. Notably, LifeStance Health Group's price-to-earnings ratio is -- while Ensign Group's PE ratio is 32.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeStance Health Group is 2.28x versus 1.90x for Ensign Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSTLifeStance Health Group2.28x -- $312.7M -$6M ENSGEnsign Group1.90x 32.64x $1.1B $78.4M
-
Which has Higher Returns LFST or GRDN?
Guardian Pharmacy Services has a net margin of -1.91% compared to LifeStance Health Group's net margin of -38.8%. LifeStance Health Group's return on equity of -6.64% beat Guardian Pharmacy Services's return on equity of -109.2%.
Company Gross Margin Earnings Per Share Invested Capital LFSTLifeStance Health Group32.12% -$0.02 $1.7B GRDNGuardian Pharmacy Services19.36% -$2.00 $178M -
What do Analysts Say About LFST or GRDN?
LifeStance Health Group has a consensus price target of --, signalling upside risk potential of 19.18%. On the other hand Guardian Pharmacy Services has an analysts' consensus of -- which suggests that it could grow by 12.1%. Given that LifeStance Health Group has higher upside potential than Guardian Pharmacy Services, analysts believe LifeStance Health Group is more attractive than Guardian Pharmacy Services.
Company Buy Ratings Hold Ratings Sell Ratings LFSTLifeStance Health Group0 0 0 GRDNGuardian Pharmacy Services0 0 0 -
Is LFST or GRDN More Risky?
LifeStance Health Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Guardian Pharmacy Services has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock LFST or GRDN?
LifeStance Health Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Guardian Pharmacy Services offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeStance Health Group pays -- of its earnings as a dividend. Guardian Pharmacy Services pays out 160.75% of its earnings as a dividend.
-
Which has Better Financial Ratios LFST or GRDN?
LifeStance Health Group quarterly revenues are $312.7M, which are smaller than Guardian Pharmacy Services quarterly revenues of $314.4M. LifeStance Health Group's net income of -$6M is higher than Guardian Pharmacy Services's net income of -$122M. Notably, LifeStance Health Group's price-to-earnings ratio is -- while Guardian Pharmacy Services's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeStance Health Group is 2.28x versus 1.13x for Guardian Pharmacy Services. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSTLifeStance Health Group2.28x -- $312.7M -$6M GRDNGuardian Pharmacy Services1.13x -- $314.4M -$122M
-
Which has Higher Returns LFST or PACS?
PACS Group has a net margin of -1.91% compared to LifeStance Health Group's net margin of -1.11%. LifeStance Health Group's return on equity of -6.64% beat PACS Group's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LFSTLifeStance Health Group32.12% -$0.02 $1.7B PACSPACS Group15.67% -$0.07 $1.1B -
What do Analysts Say About LFST or PACS?
LifeStance Health Group has a consensus price target of --, signalling upside risk potential of 19.18%. On the other hand PACS Group has an analysts' consensus of $34.83 which suggests that it could grow by 167.74%. Given that PACS Group has higher upside potential than LifeStance Health Group, analysts believe PACS Group is more attractive than LifeStance Health Group.
Company Buy Ratings Hold Ratings Sell Ratings LFSTLifeStance Health Group0 0 0 PACSPACS Group4 1 0 -
Is LFST or PACS More Risky?
LifeStance Health Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison PACS Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock LFST or PACS?
LifeStance Health Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. PACS Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeStance Health Group pays -- of its earnings as a dividend. PACS Group pays out 71.23% of its earnings as a dividend. PACS Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios LFST or PACS?
LifeStance Health Group quarterly revenues are $312.7M, which are smaller than PACS Group quarterly revenues of $981.8M. LifeStance Health Group's net income of -$6M is higher than PACS Group's net income of -$10.9M. Notably, LifeStance Health Group's price-to-earnings ratio is -- while PACS Group's PE ratio is 19.89x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeStance Health Group is 2.28x versus 0.57x for PACS Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSTLifeStance Health Group2.28x -- $312.7M -$6M PACSPACS Group0.57x 19.89x $981.8M -$10.9M
-
Which has Higher Returns LFST or PNTG?
Pennant Group has a net margin of -1.91% compared to LifeStance Health Group's net margin of 3.43%. LifeStance Health Group's return on equity of -6.64% beat Pennant Group's return on equity of 13.06%.
Company Gross Margin Earnings Per Share Invested Capital LFSTLifeStance Health Group32.12% -$0.02 $1.7B PNTGPennant Group14.01% $0.20 $296.2M -
What do Analysts Say About LFST or PNTG?
LifeStance Health Group has a consensus price target of --, signalling upside risk potential of 19.18%. On the other hand Pennant Group has an analysts' consensus of $37.20 which suggests that it could grow by 35.87%. Given that Pennant Group has higher upside potential than LifeStance Health Group, analysts believe Pennant Group is more attractive than LifeStance Health Group.
Company Buy Ratings Hold Ratings Sell Ratings LFSTLifeStance Health Group0 0 0 PNTGPennant Group2 2 0 -
Is LFST or PNTG More Risky?
LifeStance Health Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Pennant Group has a beta of 1.951, suggesting its more volatile than the S&P 500 by 95.085%.
-
Which is a Better Dividend Stock LFST or PNTG?
LifeStance Health Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pennant Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeStance Health Group pays -- of its earnings as a dividend. Pennant Group pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LFST or PNTG?
LifeStance Health Group quarterly revenues are $312.7M, which are larger than Pennant Group quarterly revenues of $180.7M. LifeStance Health Group's net income of -$6M is lower than Pennant Group's net income of $6.2M. Notably, LifeStance Health Group's price-to-earnings ratio is -- while Pennant Group's PE ratio is 40.26x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeStance Health Group is 2.28x versus 1.29x for Pennant Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSTLifeStance Health Group2.28x -- $312.7M -$6M PNTGPennant Group1.29x 40.26x $180.7M $6.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
